Richard A. Basile Co Founder and CEO of BioPontis Alliance for Rare Diseases, discusses his organization’s business model, focus on rare diseases, and willingness to partner with patients, academic centers, investors, and volunteers.

BioPontis is an international nonprofit organization whose mission is to advance promising science into potential treatments for rare neurological diseases. BioPontis Alliance for Rare Diseases is dedicated to the development of new therapeutic agents to treat rare diseases. BioPontis provides the plans and executes the preclinical translational scientific, early clinical development, patenting, and business relationship management.